Nanotechnology in Medical Devices Market Size, Share, Growth Analysis Report 2032

Nanotechnology in Medical Devices Industry Prospective:

The global nanotechnology in medical devices market size accrued earnings worth approximately USD 3.81 Billion in 2023 and is predicted to gain revenue of about USD 7.61 Billion by 2032, is set to record a CAGR of nearly 8% over the period from 2024 to 2032.

The study includes the drivers and restraints of the nanotechnology in medical devices market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the nanotechnology in medical devices market on a global and regional level.

Request Free Sample

Nanotechnology in Medical Devices Market: Overview

Nanomaterial consists of significant nano-scale dependent optical, catalytic, physical, chemical, and electric properties that can be controlled. Nanotechnology’ small size is its utility in the healthcare sector. When these particles enter the biological system, their nanoscale properties along with nano size helps them in delivery probes and vector for therapeutic, diagnostic, and imaging purposes. Due to their reduced size, the surface area of nanotechnology increases which helps in bimolecular chemical interactions. The drug delivery system with non-material can interact with bimolecular present at both the surface and within the cell. This, in turn, provides a significant amount of interaction time between the drug and the cell.

In order to give the users of this report a comprehensive view of the nanotechnology in medical devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Nanotechnology in Medical Devices Market: Growth Factors

As per the World Health Organization, cardiovascular diseases (CVDs) are the primary cause of death worldwide. About 17.5 million people died from CVDs in 2015, i.e., 31% of total global deaths. According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly one of every four deaths. As per the World Health Organization, there were 14 million new cancer cases in 2012 worldwide and 8.8 million cancer-related deaths in 2015. Globally, nearly 1 in every 6 death is caused by cancer. The global burden of CVDs and cancer is increasing, owing to the rising geriatric population base globally. The increasing prevalence of lifestyle-associated life-threatening diseases is expected to be the major driver for the global nanotechnology in medical devices market.

In addition, rising mortality rate and growing awareness and access to modern and advanced therapeutics among the patients are likely to further fuel the global nanotechnology in medical devices market in the upcoming years. Additionally, growing awareness about the advantages of therapy and huge investments made in the research and development of nanotechnology in medical devices are projected to create new growth opportunities for this market.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Request Free Sample

Nanotechnology in Medical Devices Market: Segmentation

The global nanotechnology in medical devices market is segmented based on product type and application.

By product type, the market includes biochip (lab-on-chip and DNA microarrays), implantable material (dental filling material, and bone restoring material), medical textile and wound dressing, active implant devices (cardiac rhythm management devices, hearing aid devices, and retinal implants), and others.

On the basis of application, the nanotechnology in medical devices market is divided into diagnostic, therapeutic, and research.

Nanotechnology in Medical Devices Market: Report Scope

Nanotechnology in Medical Devices Market: Regional Insights

The North American nanotechnology in medical devices market is expected to show the maximum growth over the forecast time period, owing to the developments witnessed in the healthcare infrastructure, favorable government policies and research grant. Europe was the second largest nanotechnology in medical devices market globally in 2018, due to the high per capita income of the regional population. Asia Pacific is expected to show the fastest growth rate while the Latin American market is projected to grow moderately in the years ahead.

Nanotechnology in Medical Devices Market: Competitive Space

The global nanotechnology in medical devices market profiles key players such as:

• GE Global Research
• Merck KGaA
• Ferro
• AMAG Pharmaceuticals
• Capsulution Nanoscience
• AstraZeneca
• Affymetrix
• PerkinElmer
• 3M
• Starkey Hearing Technologies
• Smith & Nephew
• St. Jude Medical
• Acusphere
• and Stryker Corporation.

This report segments the global nanotechnology in medical devices market into:

Global Nanotechnology in Medical Devices Market: By Product Type

• Biochip
  • Lab-On-Chip
  • DNA Microarrays

• Implantable Material

• Dental Filling Material
• Bone Restoring Material

• Medical Textile and Wound Dressing

• Active Implant Devices
  • Cardiac Rhythm Management Devices
  • Hearing Aid Devices
  • Retinal Implants

• Others

Global Nanotechnology in Medical Devices Market: By Application

• Diagnostic
• Therapeutic
• Research

Global Nanotechnology in Medical Devices Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa